Lemonade (LMND) has expanded its Autonomous Car insurance to Colorado, offering Tesla owners a 50% discount on miles driven using Full Self-Driving, supervised, and extra savings when bundling with other Lemonade policies.

Following the Autonomous Car launch in Colorado, Lemonade’s short term share price return has been mixed, with a 1-day gain of 5.13% and a 90-day share price return that is down 3.03%, while its 1-year total shareholder return of 39.94% and very large 3-year total shareholder return of about 2.5x point to stronger longer term momentum than recent trading suggests.

If this kind of product launch has you thinking more broadly about insurance and risk technology, it could be worth checking a curated list of 61 profitable AI stocks that aren't just burning cash

With Lemonade’s 1 year total return near 40%, a very large 3 year gain of about 2.5x, and shares still trading slightly below the average analyst target, is this a fresh buying opportunity or is future growth already priced in?

Most Popular Narrative: 10% Undervalued

The most followed narrative currently places Lemonade’s fair value at $65.11, above the last close of $58.86, which frames the recent Autonomous Car moves in a valuation context that still leaves some upside implied by that framework.

Lemonade's rapid adoption and integration of in-house AI-driven underwriting platforms and proprietary data provide a sustainable long-term efficiency advantage, leading to continued improvement in underwriting accuracy, loss ratios, operating margins, and net earnings. Accelerating momentum in core business metrics, such as seven consecutive quarters of accelerating in-force premium (IFP) growth, a dramatic 29% year-on-year IFP increase, and eight straight quarters of triple-digit growth in European IFP, demonstrates strong revenue growth potential and market expansion.

Curious what sits behind that fair value for Lemonade? The narrative leans on rapid revenue expansion, a swing from losses to profits, and a rich future earnings multiple. Want the full picture that connects those moving parts to a single number?

The most followed narrative uses a 6.98% discount rate and bakes in faster revenue growth, margin improvement and future earnings power to arrive at its $65.11 fair value. Result: Fair Value of $65.11 (UNDERVALUED)

However, Lemonade’s story could shift quickly if higher claim costs or tougher AI regulation squeeze margins and slow the automation push underpinning that 10% undervalued narrative.

Another View: Multiples Paint a Tougher Picture for Lemonade

The 10% undervalued narrative for Lemonade sits awkwardly beside its current P/S of 5.4x, compared with a US Insurance industry average of 1.2x and a peer average of 1.3x. The fair ratio of 1.4x suggests the market could instead move toward a much lower sales multiple. Is that premium a sign of opportunity or valuation risk if growth or margins fall short?

For a closer look at how this pricing gap translates into practical upside or downside risk, including how sales multiples interact with growth and profitability expectations, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment on Lemonade split between upside potential and valuation risk, it makes sense to look under the hood yourself. Act quickly to review the company’s strengths and decide if they justify the current pricing by checking the 2 key rewards.

Looking for more investment ideas beyond Lemonade?

If Lemonade has sharpened your interest in where to put your next dollar to work, do not stop here. Broaden your watchlist with a few targeted angles.

• Target potential value opportunities by scanning companies trading on attractive fundamentals using the 44 high quality undervalued stocks.
• Strengthen your income stream by reviewing stocks that offer resilient payouts and yields through the 8 dividend fortresses.
• Reduce portfolio stress by focusing on companies screened for sturdier finances with the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.